Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12596039 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL12894022 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL12596167 | 0.93 | KDM4E (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL12596192 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL12596044 | 0.92 | — | — | |
| SCHEMBL12596109 | 0.92 | KDM4E (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL12893708 | 0.91 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL10161145 | 0.89 | KDM4E (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL12596183 | 0.89 | PDK2 (0.30) | — | |
| SCHEMBL12596003 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546792-B2 | Anthracene derivative, and light emitting element, light emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| US-8546792-B2 | Anthracene derivative, and light emitting element, light emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| US-20110121275-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-05-26 | — | — | US | disclosed |
| US-7880019-B2 | 9-[N-phenyl-N-(9-phenylcarbazol-3-yl)amino]-10-phenylanthracene; high luminous efficiency; long lifetime | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-02-01 | — | — | US | disclosed |
| US-7880019-B2 | 9-[N-phenyl-N-(9-phenylcarbazol-3-yl)amino]-10-phenylanthracene; high luminous efficiency; long lifetime | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-02-01 | — | — | US | disclosed |
| US-20080086012-A1 | Anthracene Derivative, And Light Emitting Element, Light Emitting Device, And Electronic Device Using the Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-10 | — | — | US | disclosed |
| US-20080086012-A1 | Anthracene Derivative, And Light Emitting Element, Light Emitting Device, And Electronic Device Using the Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-10 | — | — | US | disclosed |
| WO-2008038607-A1 | ANTHRACENE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE USING THE ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080086012-A1 | Anthracene Derivative, And Light Emitting Element, Light Emitting Device, And Electronic Device Using the Anthracene Derivative | GLB1, CYP1A1, XPOT | KDM4E 3720/4885ATM 1176/4885L3MBTL1 716/4885 |
| US-20110121275-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Anthracene Derivative | GLB1, CYP1A1, XPOT | KDM4E 3720/4885ATM 1176/4885L3MBTL1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.